Edwards Lifesciences Corporation (EW) has 20 已知的內部人和機構持有人紀錄. 最大持有人為 Lemercier Jean-Luc M 持有 184,686 股. 其他重要持有人包括 WANG HUIMIN 和 Szyman Catherine M..
過去12個月，內部人進行了 90 筆交易，涉及 EW 股票 — 26 筆買入 (價值為 $423.15K) 和 14 筆賣出 (價值為 $7.49M). 內部人買入超過賣出，可能表明對公司前景有信心.
EW 內部人持股
最大持股人
Lemercier Jean-Luc M
184,686 股
主要內部人持股
| # |
姓名 |
職位 |
持股數量 |
最近申報日期 |
相對規模 |
| 1 |
Lemercier Jean-luc M |
CVP, Emeacla and Japac |
184,686 |
2024-07-08 |
|
| 2 |
Wang Huimin |
CVP, Japan & Intercontinental |
99,381 |
2022-07-08 |
|
| 3 |
Szyman Catherine M. |
CVP, Critical Care |
81,287 |
2024-09-03 |
|
| 4 |
Valeriani Nicholas J |
Director |
79,296 |
2025-05-09 |
|
| 5 |
Loranger Steven R |
Director |
63,900 |
2025-05-09 |
|
| 6 |
Wood Larry L |
Global President Tavr & Surg |
35,800 |
2025-08-18 |
|
| 7 |
Chopra Daveen |
CVP, Tmtt & Surgical |
32,201 |
2025-12-11 |
|
| 8 |
Marsh Martha H. |
Director |
31,880 |
2023-05-15 |
|
| 9 |
Stone Heisz Leslie |
Director |
30,948 |
2025-12-12 |
|
| 10 |
Ullem Scott B. |
CVP, Chief Financial Officer |
26,000 |
2026-03-11 |
|
| 11 |
Bobo Donald E Jr |
CVP,strategy/corp Development |
21,266 |
2026-03-02 |
|
| 12 |
Markowitz Wayne |
CVP, Japac |
17,563 |
2025-12-08 |
|
| 13 |
Sellers Robert W.a. |
SVP, Corporate Controller |
17,081 |
2024-05-13 |
|
| 14 |
Laviolette Paul A |
Director |
14,301 |
2025-05-09 |
|
| 15 |
Bruls Annette |
CVP, Emeacla |
14,171 |
2025-07-11 |
|
| 16 |
Sequeira Ramona |
Director |
11,686 |
2025-05-09 |
|
| 17 |
Zovighian Bernard J |
CEO |
11,517 |
2026-02-13 |
|
| 18 |
Dahl Andrew M. |
SVP, Corporate Controller |
9,089 |
2026-02-23 |
|
| 19 |
Davis Leslie C. |
Director |
6,583 |
2025-05-09 |
|
| 20 |
Feinberg David T |
Director |
5,836 |
2025-05-09 |
|
近期交易 (過去12個月)
| 日期 |
姓名 |
職位 |
類型 |
股數 |
股價 |
總價值 |
| 2026-04-06 |
Lippis Daniel J. |
CVP, Tavr |
期權行權（賣出） |
1,019 |
$59.26 |
$60.38K |
| 2026-04-02 |
Bobo Donald E Jr |
CVP,strategy/corp Development |
期權行權（賣出） |
22,680 |
$59.26 |
$1.34M |
| 2026-03-11 |
Lippis Daniel J. |
CVP, Tavr |
期權行權（賣出） |
1,019 |
$59.26 |
$60.38K |
| 2026-03-11 |
Ullem Scott B. |
CVP, Chief Financial Officer |
期權行權（賣出） |
13,000 |
$59.26 |
$770.34K |
| 2026-03-02 |
Bobo Donald E Jr |
CVP,strategy/corp Development |
知情賣出 |
11,340 |
$85.93 |
$974.43K |
| 2026-02-25 |
Bobo Donald E Jr |
CVP,strategy/corp Development |
知情賣出 |
24,000 |
$83.84 |
$2.01M |
| 2026-02-22 |
Dahl Andrew M. |
SVP, Corporate Controller |
RSU 預扣稅 |
176 |
$79.78 |
$14.04K |
| 2026-02-22 |
Lippis Daniel J. |
CVP, Tavr |
RSU 預扣稅 |
432 |
$79.78 |
$34.46K |
| 2026-02-17 |
Lippis Daniel J. |
CVP, Tavr |
RSU 預扣稅 |
198 |
$75.87 |
$15.02K |
| 2026-02-16 |
Lippis Daniel J. |
CVP, Tavr |
RSU 預扣稅 |
258 |
$75.87 |
$19.57K |
| 2026-02-12 |
Lippis Daniel J. |
CVP, Tavr |
限制性股票授予 (RSU) |
12,820 |
- |
- |
| 2026-02-16 |
Ullem Scott B. |
CVP, Chief Financial Officer |
RSU 預扣稅 |
199 |
$75.87 |
$15.1K |
| 2026-02-13 |
Zovighian Bernard J |
CEO |
贈與（收到） |
2,920 |
- |
- |
| 2026-02-12 |
Zovighian Bernard J |
CEO |
期權行權（賣出） |
25,350 |
$59.26 |
$1.5M |
| 2026-01-09 |
Lippis Daniel J. |
CVP, Tavr |
期權行權（賣出） |
1,019 |
$59.26 |
$60.38K |
| 2026-01-06 |
Bobo Donald E Jr |
CVP,strategy/corp Development |
知情賣出 |
8,708 |
$85.98 |
$748.71K |
| 2025-12-12 |
Lippis Daniel J. |
CVP, Japac |
期權行權（賣出） |
1,019 |
$59.26 |
$60.38K |
| 2025-12-12 |
Stone Heisz Leslie |
Director |
知情賣出 |
2,615 |
$83.41 |
$218.12K |
| 2025-12-12 |
Bobo Donald E Jr |
CVP,strategy/corp Development |
贈與（送出） |
7,100 |
- |
- |
| 2025-12-11 |
Chopra Daveen |
CVP, Tmtt & Surgical |
知情賣出 |
2,000 |
$84.38 |
$168.75K |
| 2025-12-10 |
Zovighian Bernard J |
CEO |
知情賣出 |
3,863 |
$83.45 |
$322.37K |
| 2025-12-09 |
Zovighian Bernard J |
CEO |
贈與（收到） |
3,863 |
- |
- |
| 2025-12-08 |
Zovighian Bernard J |
CEO |
期權行權（賣出） |
25,350 |
$59.26 |
$1.5M |
| 2025-12-10 |
Bobo Donald E Jr |
CVP,strategy/corp Development |
期權行權（賣出） |
11,340 |
$59.26 |
$671.97K |
| 2025-12-09 |
Ullem Scott B. |
CVP, Chief Financial Officer |
期權行權（賣出） |
7,700 |
$59.26 |
$456.28K |
